Braining - Physical Exercise in Psychiatry - Evaluation of Feasibility, and Health Among Patients
Braining Study - Implementation of Physical Activity for Patients and Staff in Specialist Psychiatry, Feasibility on Pilot Unit and Effect Evaluation in Randomized Controlled Multi-center Study.
1 other identifier
interventional
22
1 country
1
Brief Summary
Physical exercise (PE) shows beneficial effects on somatic and psychiatric symptoms. "Braining" is a clinical invention where psychiatric staff exercise together with patients to help patients start and execute PE regularly. In the present study the feasibility of the intervention will be evaluated, how Braining is perceived, and preliminary effects on health and physical activity among patients. The investigators hypothesize that patients' health and physical activity will increase after participation in Braining at the unit. Braining will be implemented at two psychiatric pilot units in Region Stockholm, Sweden. During 6 months patients will be included and treated in 12 weeks PE intervention periods. To measure feasibility patients will answer self-rating questionnaires and be invited to semi structured interviews after receiving the intervention. Health will be measured by physical examination and blood test as well as self-ratings of depression, anxiety, sleep, hypomania, and quality of life before the intervention, every 4 weeks during the intervention, post the intervention, and at follow-up 12 months post the intervention. Physical activity will be rated before, during, after the intervention and at follow-up 12 months post the intervention using International Physical Activity Questionnaires (IPAQ) and Actigraph. All patients that fulfill inclusion criteria at the units will be invited to participate in the study, approximately 50 individuals in total.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 25, 2021
CompletedFirst Posted
Study publicly available on registry
January 11, 2022
CompletedStudy Start
First participant enrolled
March 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedDecember 9, 2024
November 1, 2024
5 months
December 25, 2021
December 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (15)
Actigraph GT3x
Objectively measured physical activity and sedentary time: Total physical activity as counts/day and time spent in sedentary, low, moderate and vigorous intensity as min/day.
Change from inclusion to follow up 3 months after inclusion
Actigraph GT3x
Objectively measured physical activity and sedentary time: Total physical activity as counts/day and time spent in sedentary, low, moderate and vigorous intensity as min/day.
At follow up 12 months after intervention.
International Physical Activity Questionnaires (IPAQ)
Self-reported physical activity: Total physical activity as Metabolic Energy Turnover (MET)hours/week and three level categories (low, moderate and high).
Change from inclusion to follow up 3 months after inclusion
International Physical Activity Questionnaires (IPAQ)
Self-reported physical activity: Total physical activity as Metabolic Energy Turnover (MET)hours/week and three level categories (low, moderate and high).
At follow up 12 months after intervention.
Patient Health Questionnaire 9 (PHQ-9)
Self rated depressive symptoms. Minimum value 0, maximum value 27, where higher values indicate more depressive symptoms.
Change from inclusion to follow up 3 months after inclusion
Patient Health Questionnaire 9 (PHQ-9)
Self rated depressive symptoms. Minimum value 0, maximum value 27, where higher values indicate more depressive symptoms.
At follow up 12 months after intervention.
Alcohol Use Disorders Identification Test AUDIT
Self rated alcohol use. Minimum value 0, maximum value 32, where higher values indicate higher alcohol use.
Change from inclusion to follow up 3 months after inclusion
Alcohol Use Disorders Identification Test AUDIT
Self rated alcohol use. Minimum value 0, maximum value 32, where higher values indicate higher alcohol use.
At follow up 12 months after intervention.
Drug Use Disorders Identification Test DUDIT
Self rated drug use. Minimum value 0, maximum value 44, where higher values indicate higher drug use.
Change from inclusion to follow up 3 months after inclusion
Drug Use Disorders Identification Test DUDIT
Self rated drug use. Minimum value 0, maximum value 44, where higher values indicate higher drug use.
At follow up 12 months after intervention.
Brunnsviken Brief Quality of Life Questionnaire (BBQ)
Self rated quality of life. Minimum value 0, maximum value 96, where higher values indicate higher quality of life satisfaction.
Change from inclusion to follow up 3 months after inclusion
Brunnsviken Brief Quality of Life Questionnaire (BBQ)
Self rated quality of life. Minimum value 0, maximum value 96, where higher values indicate higher quality of life satisfaction.
At follow up 12 months after intervention.
Acceptability of treatment among patients
Semi-structured interviews
At follow up 3-5 months after inclusion
The Credibility/Expectancy Questionnaire (CEQ)
Self rated Credibility of treatment. Minimum value 3, maximum value 27 for each factor, where higher values indicate greater Credibility/Expectancy of the treatment.
Week 1 of treatment
The Client Satisfaction Questionnaire-8 (CSQ-8)
Self rated satisfaction of treatment. Minimum value 8, maximum value 32 where higher values indicate greater satisfaction with the treatment.
post treatment, 12 weeks after enrollment
Secondary Outcomes (35)
Generalised Anxiety Disorder 7-item scale (GAD-7)
Change from inclusion to follow up 3 months after inclusion
Generalised Anxiety Disorder 7-item scale (GAD-7)
At follow up 12 months after intervention.
Insomnia Severity Index (ISI)
Change from inclusion to follow up 3 months after inclusion
Insomnia Severity Index (ISI)
At follow up 12 months after intervention.
World health organization disability assessment schedule (WHODAS 2.0)
Change from inclusion to follow up 3 months after inclusion
- +30 more secondary outcomes
Study Arms (1)
Physical activity
EXPERIMENTALPatients are encouraged to participate in physical exercise at the psychiatric unit
Interventions
"Braining" is a clinical invention that helps patients in psychiatry to start and execute physical exercise (PE) regularly in psychiatric care. The core components are basic moderate to vigorous aerobic group training session and motivational work led by the psychiatric staff. Braining is used as add-on treatment to regular psychiatric care and is included in the patient care plan.
Eligibility Criteria
You may qualify if:
- Patient at the psychiatric unit
You may not qualify if:
- Severe mental disorder such as ongoing mania, psychosis, and conditions when high risk of suicide or high risk of violence available according to the assessment of psychiatric staff at the unit.
- Medical conditions such as heart or lung disease, infection, abstinence where heart rate-increasing physical activity is considered contraindicated due to Medical reasons.
- Physical disability that makes it impossible to move independently to the gym and performing the indicated exercise in the training sessions.
- Mental disability which means that you can not participate in group training.
- Difficulty speaking or understanding the Swedish language.
- Ongoing heavy substance use.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Stockholmlead
- Karolinska Institutetcollaborator
Study Sites (1)
Region Stockholm, Liljeholmsberget
Stockholm, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 25, 2021
First Posted
January 11, 2022
Study Start
March 2, 2022
Primary Completion
July 31, 2022
Study Completion
September 30, 2023
Last Updated
December 9, 2024
Record last verified: 2024-11